TY - JOUR
T1 - The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression
T2 - data from the UK Biobank cohort
AU - Singh, Sanjula D.
AU - Rivier, Cyprien A.
AU - Papier, Keren
AU - Chemali, Zeina
AU - Gutierrez-Martinez, Leidys
AU - Parodi, Livia
AU - Mayerhofer, Ernst
AU - Senff, Jasper
AU - Clocchiatti-Tuozzo, Santiago
AU - Nunley, Courtney
AU - Newhouse, Amy
AU - Ouyang, An
AU - Westover, M. Brandon
AU - Tanzi, Rudolph E.
AU - Lazar, Ronald M.
AU - Pikula, Aleksandra
AU - Ibrahim, Sarah
AU - Brouwers, H. Bart
AU - Howard, Virginia J.
AU - Howard, George
AU - Yechoor, Nirupama
AU - Littlejohns, Thomas
AU - Sheth, Kevin N.
AU - Rosand, Jonathan
AU - Fricchione, Gregory
AU - Anderson, Christopher D.
AU - Falcone, Guido J.
N1 - Publisher Copyright:
Copyright © 2024 Singh, Rivier, Papier, Chemali, Gutierrez-Martinez, Parodi, Mayerhofer, Senff, Clocchiatti-Tuozzo, Nunley, Newhouse, Ouyang, Westover, Tanzi, Lazar, Pikula, Ibrahim, Brouwers, Howard, Howard, Yechoor, Littlejohns, Sheth, Rosand, Fricchione, Anderson and Falcone.
PY - 2024/7/23
Y1 - 2024/7/23
N2 - Introduction: The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by encouraging lifestyle changes. Given that late-life depression is increasingly recognized to share risk factors with stroke and dementia, and is an important clinical endpoint for brain health, we tested the hypothesis that a higher BCS is associated with a reduced incidence of future depression. Additionally, we examined its association with a brain health composite outcome comprising stroke, dementia, and late-life depression. Methods: The BCS was derived from the United Kingdom Biobank baseline evaluation in participants with complete data on BCS items. Associations of BCS with the risk of subsequent incident late-life depression and the composite brain health outcome were estimated using multivariable Cox proportional hazard models. These models were adjusted for age at baseline and sex assigned at birth. Results: A total of 363,323 participants were included in this analysis, with a median BCS at baseline of 12 (IQR: 11-14). There were 6,628 incident cases of late-life depression during a median follow-up period of 13 years. Each five-point increase in baseline BCS was associated with a 33% lower risk of incident late-life depression (95% CI: 29%-36%) and a 27% lower risk of the incident composite outcome (95% CI: 24%-30%). Discussion: These data further demonstrate the shared risk factors across depression, dementia, and stroke. The findings suggest that a higher BCS, indicative of healthier lifestyle choices, is significantly associated with a lower incidence of late-life depression and a composite brain health outcome. Additional validation of the BCS is warranted to assess the weighting of its components, its motivational aspects, and its acceptability and adaptability in routine clinical care worldwide.
AB - Introduction: The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by encouraging lifestyle changes. Given that late-life depression is increasingly recognized to share risk factors with stroke and dementia, and is an important clinical endpoint for brain health, we tested the hypothesis that a higher BCS is associated with a reduced incidence of future depression. Additionally, we examined its association with a brain health composite outcome comprising stroke, dementia, and late-life depression. Methods: The BCS was derived from the United Kingdom Biobank baseline evaluation in participants with complete data on BCS items. Associations of BCS with the risk of subsequent incident late-life depression and the composite brain health outcome were estimated using multivariable Cox proportional hazard models. These models were adjusted for age at baseline and sex assigned at birth. Results: A total of 363,323 participants were included in this analysis, with a median BCS at baseline of 12 (IQR: 11-14). There were 6,628 incident cases of late-life depression during a median follow-up period of 13 years. Each five-point increase in baseline BCS was associated with a 33% lower risk of incident late-life depression (95% CI: 29%-36%) and a 27% lower risk of the incident composite outcome (95% CI: 24%-30%). Discussion: These data further demonstrate the shared risk factors across depression, dementia, and stroke. The findings suggest that a higher BCS, indicative of healthier lifestyle choices, is significantly associated with a lower incidence of late-life depression and a composite brain health outcome. Additional validation of the BCS is warranted to assess the weighting of its components, its motivational aspects, and its acceptability and adaptability in routine clinical care worldwide.
KW - brain health
KW - dementia
KW - depression - epidemiology
KW - prevention
KW - risk factor
KW - stroke
UR - https://www.scopus.com/pages/publications/85200450693
U2 - 10.3389/fpsyt.2024.1373797
DO - 10.3389/fpsyt.2024.1373797
M3 - Article
AN - SCOPUS:85200450693
SN - 1664-0640
VL - 15
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1373797
ER -